APA

Shide K., Kameda T., Markovtsov V., Shimoda H. K., Tonkin E., Fang S., Liu C., Gelman M., Lang W., Romero J., McLaughlin J., Bhamidipati S., Clough J., Low C., Reitsma A., Siu S., Pine P., Park G., Torneros A., Duan M., Singh R., Payan D. G., Matsunaga T., Hitoshi Y. & Shimoda K. (20110905). R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. : Blood.

Chicago

Shide Kotaro, Kameda Takuro, Markovtsov Vadim, Shimoda Haruko K, Tonkin Elizabeth, Fang Shuling, Liu Chian, Gelman Marina, Lang Wayne, Romero Jason, McLaughlin John, Bhamidipati Somasekhar, Clough Jeffrey, Low Caroline, Reitsma Andrea, Siu Stacey, Pine Polly, Park Gary, Torneros Allan, Duan Matt, Singh Rajinder, Payan Donald G, Matsunaga Takuya, Hitoshi Yasumichi and Shimoda Kazuya. 20110905. R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. : Blood.

Harvard

Shide K., Kameda T., Markovtsov V., Shimoda H. K., Tonkin E., Fang S., Liu C., Gelman M., Lang W., Romero J., McLaughlin J., Bhamidipati S., Clough J., Low C., Reitsma A., Siu S., Pine P., Park G., Torneros A., Duan M., Singh R., Payan D. G., Matsunaga T., Hitoshi Y. and Shimoda K. (20110905). R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. : Blood.

MLA

Shide Kotaro, Kameda Takuro, Markovtsov Vadim, Shimoda Haruko K, Tonkin Elizabeth, Fang Shuling, Liu Chian, Gelman Marina, Lang Wayne, Romero Jason, McLaughlin John, Bhamidipati Somasekhar, Clough Jeffrey, Low Caroline, Reitsma Andrea, Siu Stacey, Pine Polly, Park Gary, Torneros Allan, Duan Matt, Singh Rajinder, Payan Donald G, Matsunaga Takuya, Hitoshi Yasumichi and Shimoda Kazuya. R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm. : Blood. 20110905.